Patents by Inventor Menci Kunstelj

Menci Kunstelj has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing a composition of pegylated proteins
    Publication number: 20160058878
    Abstract: This invention is in the field of protein pegylation. In particular, it relates to a method for pegylating therapeutic proteins. The invention also relates to the use of such pegylated therapeutic polypeptides for treating muscle diseases and disorders.
    Type: Application
    Filed: December 11, 2014
    Publication date: March 3, 2016
    Applicant: NOVARTIS AG
    Inventors: Simona JEVSEVAR, Menci KUNSTELJ, Barbara PODOBNIK
  • Selenium containing modifying agents and conjugates
    Patent number: 8389695
    Abstract: The invention relates to a modifying agent comprising a water soluble polymer, wherein the water soluble polymer comprises at least one reactive selenium group, said reactive selenium group being capable of reacting with a thiol group thereby forming an —Se—S— bond. Furthermore, the invention relates to a method for producing said modifying agents and their use in the modification of pharmaceutically active agents, e.g. G-CSF. Additionally, the invention concerns conjugates comprising a water-soluble polymer and a pharmaceutically active agent, wherein the water-soluble polymer is linked via a S—Se-bond to agent and a method for their production and their use as medicaments. Finally, the invention concerns a pharmaceutical composition comprising the inventive conjugates.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: March 5, 2013
    Assignee: Lek Pharmaceuticals D.D.
    Inventors: Menci Kunstelj, Gabriela Ambrozic, Vladka Gaberc Porekar, Veronika Verbic
  • SELENIUM CONTAINING MODIFYING AGENTS AND CONJUGATES
    Publication number: 20110092420
    Abstract: The invention relates to a modifying agent comprising a water soluble polymer, wherein the water soluble polymer comprises at least one reactive selenium group, said reactive selenium group being capable of reacting with a thiol group thereby forming an —Se—S— bond. Furthermore, the invention relates to a method for producing said modifying agents and their use in the modification of pharmaceutically active agents, e.g. G-CSF. Additionally, the invention concerns conjugates comprising a water-soluble polymer and a pharmaceutically active agent, wherein the water-soluble polymer is linked via a S—Se-bond to agent and a method for their production and their use as medicaments. Finally, the invention concerns a pharmaceutical composition comprising the inventive conjugates.
    Type: Application
    Filed: February 13, 2009
    Publication date: April 21, 2011
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Menci Kunstelj, Viktor Menart, Verpmola Verbic, Gabriela Ambrozic, Vladka Gaberc Porekar